Cargando…
Preoperative oral pentoxifylline in case of coronary artery bypass grafting with left ventricular dysfunction (ejection fraction equal to/less than 30%)
OBJECTIVE: Most coronary artery bypass grafts are done by applying cardiopulmonary bypass, which usually induces unwanted inflammatory reactions and impairs the outcomes. In order to minimize the perilous response of cardiopulmonary bypass, pentoxifylline was getting used orally. METHODS: In a prosp...
Autores principales: | Mansourian, Soheil, Bina, Payvand, Fehri, Arezoo, Karimi, Abbas Ali, Boroumand, Mohammad Ali, Abbasi, Kyomars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368455/ https://www.ncbi.nlm.nih.gov/pubmed/25880052 http://dx.doi.org/10.5152/akd.2014.5883 |
Ejemplares similares
-
Author`s Reply
por: Mansourian, Soheil, et al.
Publicado: (2015) -
Author’s Reply
por: Mansourian, Soheil, et al.
Publicado: (2015) -
Preoperative oral pentoxifylline in case of coronary artery bypass grafting with left ventricular dysfunction (ejection fraction equal to/less than 30%)
por: Özçem, Barçın, et al.
Publicado: (2015) -
Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality of Coronary Artery Bypass Grafting
por: Sharafi, Ahmad, et al.
Publicado: (2013) -
Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality
por: Salehi Omran, Abbas, et al.
Publicado: (2007)